Generated Narrative: Composition composition-en-d4bcbbaec04bf6aceb2f71162205967e Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//68290 status: Final type: Package Leaflet category: Raw date: 2022-02-16 13:28:17+0000 author: Organization Laboratorios Farmacéuticos ROVI, S.A. title: TEST PURPOSES ONLY - Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes Attesters - Mode Time * Official 2022-02-16 13:28:17+0000
TEST PURPOSES ONLY - Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes
unavailable
Package leaflet: Information for the user
Leaflet: Information for the user Calcium/Vitamin D3 ROVI 1000 mg / 880 IU effervescent tablets Calcium carbonate/cholecalciferol (Vitamin D3) Read this leaflet carefully before you start taking this medicine, as it contains important information for you. -Keep this leaflet. You may need to read it again. -If you have any questions, ask your doctor or pharmacist. -This medicine has been prescribed for you only. Do not give it to others, even if they have the same symptoms as you, as it may harm them. -If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Contents of the leaflet What Calcium/Vitamin D3 ROVI is and what it is used for What you need to know before you start taking Calcium/Vitamin D3 ROVI How to take Calcium/Vitamin D3 ROVI Possible side effects Storage of Calcium/Vitamin D3 ROVI Package contents and additional information
1. What CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES is and what it is used for
Calcium/Vitamin D3 ROVI are effervescent tablets. They are available in packages containing 30 tablets. This medicine is a combination of calcium and vitamin D, indicated for the correction of combined vitamin D and calcium deficiency in elderly patients, as well as a supplement of vitamin D and calcium as an adjunct to specific therapy for the treatment of osteoporosis in patients with deficiency or at high risk of combined vitamin D and calcium deficiency.
2. What you need to know before you take CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
Do not take Calcium/Vitamin D3 ROVI: if you are allergic to the active ingredients or any of the other components of this medicine (listed in section 6), if you have hypercalcemia (abnormally high levels of calcium in the blood), if you have hypercalciuria (excessive calcium in the urine), if you have kidney stones, tissue calcification (deposition of calcium salts in tissues), if you suffer from chronic kidney disease, if you have prolonged immobilization accompanied by hypercalciuria and/or hypercalcemia. This medicine contains soybean oil. Do not use it if you are allergic to peanuts or soy. Warnings and precautions: Consult your doctor or pharmacist before starting Calcium/Vitamin D3 ROVI: - if you have renal insufficiency (kidney impairment), - if you have kidney stones, - if you suffer from heart disease, sarcoidosis (inflammation affecting lymph nodes, lungs, liver, eyes, skin, and other tissues), or are undergoing treatment with cardiac glycosides (used for heart failure), - if you are taking other vitamin D products, or are undergoing prolonged or high-dose calcium supplementation. In this case, your doctor may need to conduct regular clinical monitoring. Your doctor will advise on the frequency of these checks. Taking Calcium/Vitamin D3 ROVI with other medicines: Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines. Certain medicines can interact with Calcium/Vitamin D3 ROVI, requiring dose adjustments, interruption, or at least a few hours between administrations. It is important to inform your doctor if you are taking or have recently taken any of the following medications: Cardiac glycosides (for heart conditions). Tetracyclines (certain antibiotics); wait at least 3 hours between doses. Thiazide diuretics (medications that increase urine output). Anticonvulsants. Systemic corticosteroids. Bisphosphonates and sodium fluoride; wait at least 3 hours between doses. Barbiturates or phenytoin. Taking Calcium / Vitamin D3 ROVI with food and drinks: If taken with foods and drinks containing oxalic acid (found in spinach and rhubarb), phytic acid (found in whole-grain bread and cereals), or phosphorus (found in milk), interactions may occur. Avoid taking this medicine within 2 hours after consuming such foods. Pregnancy and breastfeeding If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a baby, consult your doctor or pharmacist before using this medicine. Due to the vitamin D content (880 IU) of Calcium/Vitamin D3 ROVI, its use is not recommended during pregnancy and breastfeeding, as the recommended daily dose of vitamin D should not exceed 600 IU/day. Driving and using machines: No effects on driving or operating machinery have been reported. Calcium/Vitamin D3 ROVI contains sucrose, sodium, lactose, and glucose. This medicine contains sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine. It may cause cavities. This medicine contains 96.15 mg of sodium (a main component of table salt) per tablet. This is equivalent to 4.8% of the maximum recommended daily intake of sodium for an adult. This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine. This medicine contains glucose (in maltodextrin derived from corn). If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
3. How to take CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
Follow the administration instructions for this medicine as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again. Dosage Adults The recommended dose is 1 effervescent tablet (1000 mg of calcium and 880 IU of Vitamin D3) per day. Method and route of administration This medicine is administered orally. Dissolve the tablet in a glass of water and drink immediately. Duration of treatment Your doctor will indicate the duration of your treatment with Calcium/Vitamin D3 ROVI. Do not stop treatment earlier. Follow these instructions unless your doctor gives you different directions. In such cases, it is advisable to request written instructions from the doctor and ensure you fully understand them. If you think the effect of Calcium/Vitamin D3 ROVI is too strong or too weak, inform your doctor or pharmacist. Remember to take your medicine. If you take more Calcium/Vitamin D3 ROVI than you should If you take more Calcium/Vitamin D3 ROVI than you should, or in case of overdose or accidental ingestion, immediately consult your doctor or pharmacist or call the Toxicology Information Service at 91.562.04.20, indicating the medicine and the amount ingested. Overdose can cause hypervitaminosis D (excess vitamin D) and hypercalcemia (abnormally high levels of calcium in the blood). Symptoms of overdose include nausea, vomiting, anorexia (eating disorder), abdominal pain, dry mouth, or polyuria (increased urine output), or irritability, lethargy (excessive fatigue), stupor (decreased response to stimuli), and coma (loss of consciousness) in severe cases. If you forgot to take Calcium/Vitamin D3 ROVI Do not take a double dose to make up for missed doses. If you stop taking Calcium/Vitamin D3 ROVI If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. -Uncommon (may affect between 1 and 10 in 1,000 patients): high calcium levels in the blood (hypercalcemia), high calcium levels in the urine (hypercalciuria). -Rare (may affect between 1 and 10 in 10,000 patients): constipation, flatulence, nausea, epigastric pain, diarrhea. -Very rare (may affect fewer than 1 in 10,000 patients): itching (pruritus), skin rash (exanthema), hives (urticaria). Reporting of side effects If you experience any side effects, talk to your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
Keep this medicine out of the sight and reach of children. Store in the original package to protect it from moisture. Do not use this medicine after the expiry date stated on the package after EXP. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Take unused packaging and medicines to the SIGRE Point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. This will help protect the environment.
6. Contents of the pack and other information
Composition of Calcium/Vitamin D3 ROVI -The active ingredients are: calcium carbonate and concentrated cholecalciferol (in powder form). Each tablet contains 2500 mg of calcium carbonate (equivalent to 1,000 mg of calcium) and 22 micrograms of concentrated cholecalciferol in powder form (equivalent to 880 IU of cholecalciferol = vitamin D3). -The other components (excipients) are: anhydrous citric acid, sodium bicarbonate, lactose monohydrate, povidone, sodium saccharin, sodium cyclamate, macrogol 6000, orange flavor (contains maltodextrin derived from corn), simethicone emulsion, ?-tocopherol, hydrogenated soybean oil, gelatin, sucrose, and gluten-free corn starch. Product appearance and package contents Cylindrical effervescent tablets, white or whitish in color. They are presented in polypropylene tubes, each containing 15 effervescent tablets. Each package contains two tubes (30 effervescent tablets). Marketing authorization holder Laboratorios Farmacéuticos ROVI, S.A. C/ Julián Camarillo, 35 28037 - Madrid Spain Manufacturer: Laboratorios Losan Pharma GMBH Otto-Hahn-Strasse 13 79395 - Neuenburg Germany Date of the last revision of this leaflet: July 2019 Detailed information about this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (https://www.aemps.gob.es/)
Generated Narrative: Ingredient ingredient-for-calciovitaminad-calciumcarbonate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/H0G9379FGK (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * Calcium Carbonate Strengths - Presentation[x] Basis * 2500 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-cholecalciferol Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/1C6V77QF41 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * cholecalciferol Strengths - Presentation[x] Basis * 22 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-sodium Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/9NEZ333N27 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * Sodium Strengths - Presentation[x] Basis * 96 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-lactosemonohydrate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/EWQ57Q8I5X (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * lactose monohydrate Strengths - Presentation[x] Basis * 396 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-sucrose Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/C151H8M554 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * sucrose Strengths - Presentation[x] Basis * 3 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-hydrogenatedsoybeanoil Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/A2M91M918C (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: active substance Codes - Concept * hydrogenated soybean oil Strengths - Presentation[x] Basis * 0 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
Generated Narrative: Ingredient ingredient-for-calciovitaminad-anhydrouscitricacid Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/XF417D3PSL (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * Anhydrous citric acid
Generated Narrative: Ingredient ingredient-for-calciovitaminad-sodiumbicarbonate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/8MDF5V39QO (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * sodium bicarbonate
Generated Narrative: Ingredient ingredient-for-calciovitaminad-povidone Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/FZ989GH94E (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * povidone
Generated Narrative: Ingredient ingredient-for-calciovitaminad-saccharinsodium Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/SB8ZUX40TY (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * saccharin sodium
Generated Narrative: Ingredient ingredient-for-calciovitaminad-sodiumcyclamate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/1I6F42RME1 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * sodium cyclamate
Generated Narrative: Ingredient ingredient-for-calciovitaminad-macrogol6000 Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/30IQX730WE (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Effervescent tablet; unitOfPresentation = tablet role: excipient substance Codes - Concept * macrogol 6000
Generated Narrative: SubstanceDefinition substance-calciumcarbonate Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//H0G9379FGK (use: official, ) version: 1 status: Active manufacturer: Organization Laboratorios Farmacéuticos ROVI, S.A. MolecularWeights - Type Amount * exact 100.09 Structures - MolecularFormula * CO3.Ca Names - Name Type * CALCII CARBONAS [WHO-IP LATIN] Chemical Name
Generated Narrative: AdministrableProductDefinition ap-925dad38f0afbba36223a82b3a766438 Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/xx status: Active formOf: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: Effervescent tablet unitOfPresentation: tablet producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet routeOfAdministration code: Oral use TargetSpecies - Code * Human
Generated Narrative: RegulatedAuthorization authorization925dad38f0afbba36223a82b3a7664380 identifier: https://spor.ema.europa.eu/pmswi/68290 (use: official, ) subject: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription type: Marketing Authorisation status: Active statusDate: 2012-01-01 holder: Organization Laboratorios Farmacéuticos ROVI, S.A.
Generated Narrative: Organization mah-b7afabe350ac415f70e662ba6c703030 Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/xx (use: official, ) active: true type: Marketing authorisation holder name: Laboratorios Farmacéuticos ROVI, S.A. Contacts - Address * C/ Julián Camarillo, 35 Madrid ES(work)
Generated Narrative: PackagedProductDefinition ppd-740c0d6d7605c10cb166cd0ee16908f9 identifier: https://spor.ema.europa.eu/pmswi/x (use: official, ) name: Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes 30 type: Chemical Medicinal Prodcut packageFor: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290,https://www.who-umc.org/phpid#0xF79CABF272B6A7EEF104DDDA44E82716; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2012-01-03 containedItemQuantity: 2500 mg (Details: UCUM codemg = 'mg') copackagedIndicator: false packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Blister quantity: 30 material: cardboard containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#68290 (use: official, ); status = active; manufacturedDoseForm = Effervescent tablet; unitOfPresentation = tablet
Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes 30
Generated Narrative: MedicinalProductDefinition mpd4bcbbaec04bf6aceb2f71162205967e Profile: MedicinalProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/68290, https://www.who-umc.org/phpid/0xF79CABF272B6A7EEF104DDDA44E82716 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes type: Full name part part: Calcio/Vitamina type: Invented name part part part: Calcium carbonate/Vitamin D3 type: Scientific name part part part: 2500 mg type: Strength part part part: Effervescent tablet type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * Spain Spain English
Medicinal product subject to medical prescription
Calcio/Vitamina D3 ROVI 1000 mg/880 UI comprimidos efervescentes
Generated Narrative: ManufacturedItemDefinition mid-925dad38f0afbba36223a82b3a766438 Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/68290 (use: official, ) status: Active manufacturedDoseForm: Effervescent tablet unitOfPresentation: tablet